Gametes are highly specialized cells that can give rise to the next generation through their ability to generate a totipotent zygote. In mice, germ cells are first specified in the developing embryo around embryonic day (E) 6.25 as primordial germ cells (PGCs) 1 . Following subsequent migration into the developing gonad, PGCs undergo a wave of extensive epigenetic reprogramming around E10.5-E11.5 2-11 , including genome-wide loss of 5-methylcytosine 2-5,7-11 . The underlying molecular mechanisms of this process have remained unclear, leading to our inability to recapitulate this step of germline development in vitro 12-14 . Here we show, using an integrative approach, that this complex reprogramming process involves coordinated interplay among promoter sequence characteristics, DNA (de)methylation, the polycomb (PRC1) complex and both DNA demethylation-dependent and -independent functions of TET1 to enable the activation of a critical set of germline reprogramming-responsive genes involved in gamete generation and meiosis. Our results also reveal an unexpected role for TET1 in maintaining but not driving DNA demethylation in gonadal PGCs. Collectively, our work uncovers a fundamental biological role for gonadal germline reprogramming and identifies the epigenetic principles of the PGC-to-gonocyte transition that will help to guide attempts to recapitulate complete gametogenesis in vitro.
are consistently an order of magnitude lower than either total levels of 5mC at E10.5 or the amount of 5mC lost between E10.5 and E11.5 (Fig. 1b, c) , demonstrating that global DNA demethylation is not accompanied by a reciprocal increase in levels of 5hmC, as has previously been suggested 3, 17 .
Consistent with our LC-MS/MS measurements, WGBS analysis revealed near-complete loss of combined 5mC and 5hmC between E10.5 and E11.5 at features within uniquely mapped regions of the genome, with limited amounts of further DNA demethylation observed between E11.5 and E12.5 (Extended Data Fig. 3a ). Loss of DNA methylation was also observed at consensus repeat sequences, although some repetitive elements such as long interspersed nuclear element (LINE)-1A and endogenous retrovirus-intracisternal A particle (ERV-IAP) retrotransposons retained comparatively high combined levels of 5mC and 5hmC in E12.5 PGCs, as previously described 8 (Extended Data Fig. 3b ). Detailed analysis of 5hmC localization by Aba-seq in E10.5 PGCs revealed that, although global levels are lower ( Fig. 1b) , 5hmC localization in PGCs is remarkably similar to that of serumgrown mouse ES cells, even at imprint control regions (ICRs) (Extended Data Fig. 2a , b, f). Overall, 5hmC was enriched at putative active enhancers, present in intergenic regions and gene bodies, depleted at promoters, and absent on the vast majority of CpG islands (Extended Data Fig. 2b-f ). With respect to transcription ( Supplementary Table 7 ), both 5mC and 5hmC at promoter regions show an inverse relationship with gene expression levels (Extended Data Fig. 2c ). Within gene bodies, 5mC and 5hmC are clearly enriched at expressed genes when compared to genes without detectable expression. A nonlinear relationship with gene expression is observed for 5hmC, whereas the combined levels of 5mC and 5hmC show a clear positive correlation with gene expression (Extended Data Fig. 2c ).
Detailed analysis of 5hmC patterns across examined developmental stages showed that the majority of 5hmC is lost from uniquely mapped regions of the genome and re-localized to repetitive elements ( Fig. 1d , Extended Data Fig. 3a, b ). This relocalization was also clearly evident by immunofluorescence staining (Fig. 1e ). Our data thus show that during reprogramming both 5mC and 5hmC are lost in PGCs throughout the uniquely mapped regions of the genome, although levels of 5hmC show a more gradual decrease (Extended Data Fig. 4b ). However, this is not consistent with passive dilution of 5hmC through cell division 3 , as demonstrated by poor Pearson and Spearman's correlations between stages (Extended Data Fig. 4a, 5a ). To the contrary, we conclude that 5hmC is a dynamic mark in PGCs.
We next explored the relationship between 5hmC deposition and DNA demethylation in gonadal PGCs between E10.5 and E12.5 for all initially methylated 2-kb windows (that is, windows with a minimum of 20% methylation at E10.5). DNA demethylation involving a 5hmC intermediate predicts a direct correlation between 5hmC appearance Letter reSeArCH and 5mC loss (Extended Data Fig. 5a, b ). However, we observed no correlation for E10.5 or E11.5 PGCs between either the total or relative levels of 5hmC and the extent to which the combined levels of 5mC and 5hmC decreased between these two stages (Extended Data Fig. 4c-f ). Notably, for all initially methylated 2-kb windows, we did observe a negative correlation between the relative level of 5hmC and the combined levels of 5mC and 5hmC at E11.5 (Extended Data Fig. 4g ). Thus, 5hmC represents a much higher proportion of the combined levels of 5mC and 5hmC at regions that are newly hypomethylated at E11.5, regardless of their original DNA methylation levels. Although 5hmC-depleted regions contain slightly more 5mC at E11.5 than regions enriched for 5hmC, sequences depleted of 5hmC in both E10.5 and E11.5 PGCs still undergo considerable DNA demethylation between these two stages (Extended Data Fig. 4h , i), indicating that the presence of detectable 5hmC is not a prerequisite for 5mC loss in gonadal PGCs. Our observations thus implicate involvement of 5hmC in the regulation of the locus-specific post-DNA-demethylation 5mC levels in germ cells rather than in the initial wave of global DNA demethylation (Extended Data Fig. 5c ).
To expand on this observation, we used a previously published Tet1 −/− mouse model 18 (Extended Data Fig. 6a-c) . Initial LC-MS/ MS analysis revealed that loss of TET1 leads to approximately 50% reduction in global levels of 5hmC in E10.5 Tet1 −/− germ cells (Fig. 2c ). In agreement with the high level of TET1 expression at E12.5 3, 9, 11 (Extended Data Fig. 6a-c) , LC-MS/MS analysis also confirmed that TET1 represents the primary 5mC oxygenase in demethylated PGCs, with a decrease of approximately 85% in global levels of 5hmC observed in E14.5 Tet1 −/− germ cells ( Fig. 2a, c) . Importantly, the genomes of both Tet1 −/− and wild-type PGCs reached near-complete depletion of 5mC by E13.5 (Fig. 2b, d) , highlighting that TET1-mediated 5mC oxidation is not directly responsible for the bulk of DNA demethylation in gonadal PGCs.
In support of our LC-MS/MS measurements, reduced representation bisulfite sequencing (RRBS) detected only a limited number of differentially methylated regions in E14.5 Tet1 −/− PGCs ( Fig. 2e) . Notably, these regions initially undergo extensive DNA demethylation in both Tet1 −/− and wild-type PGCs, after which there is an increase in levels of 5mC between E12.5 and E14.5 specifically in Tet1 −/− PGCs ( Fig. 2e ). By contrast, levels of 5mC remain stable and/or undergo a slight further reduction between these stages in wild-type germ cells ( Fig. 2e ). The same DNA demethylation-remethylation kinetics were also observed at the few examples of previously reported 9,10 germline gene promoters and ICRs that were found to be hypermethylated in E14.5 Tet1 −/− PGCs using RRBS (Extended Data Fig. 6d , e, Supplementary Table 8 ). Although considerable enrichment of 5mC is indeed observed at the Dazl promoter by targeted bisulfite sequencing in demethylated PGCs, the extent of hypermethylation observed at the Peg3 and intergenic differentially methylated region (IG-DMR) ICRs is very limited (Extended Data Fig. 6f, g) . Furthermore, for all three regions, very few clones showed full methylation and a number of clones had heterogeneous methylation patterns consistent with a stochastic failure to remove aberrant residual and/or de novo DNA methylation in Tet1 −/− PGCs (Extended Data Fig. 6f, g) .
We next analysed the observed 5mC and 5hmC dynamics in combination with RNA sequencing (RNA-seq) datasets derived from E10.5-E14.5 PGCs (Extended Data Fig. 7 ). Initial clustering analysis of all genes on the basis of the dynamics of their promoter DNA methylation revealed that, although most promoters become completely demethylated, there is a small subset of transcriptionally silenced promoters that retain high levels of 5mC and 5hmC during global DNA demethy lation (cluster 2; Extended Data Fig. 7a ). These promoters overlap significantly with LINE1-and long terminal repeat (LTR)-containing endogenous retroviruses (P = 9.5 × 10 −24 and P = 7.2 × 10 −83 , respectively; hypergeometric test) that are likely to determine this epigenetic status (Extended Data Fig. 3b ). Overall, although high levels of 5mC and 5hmC at promoters are associated with transcriptional repression in E10.5 pre-reprogramming PGCs, loss of these marks does not generally result in transcriptional activation (Extended Data Fig. 7a ).
As the influence of 5mC on the transcriptional activity of a gene has been shown in mammals to be highly dependent on promoter CpG Letter reSeArCH content 19 , we performed clustering analysis specifically at genes with either high-CpG (HCPs), intermediate-CpG (ICPs) or low-CpG (LCPs) promoters 19 (Fig. 3a and Extended Data Fig. 7b , c). Notably, this yielded a group of HCP genes that became demethylated during the course of germline epigenetic reprogramming, and showed progressive transcriptional activation (cluster 3; Fig. 3a ). Differential expression analysis confirmed that these genes are significantly enriched among all genes that are upregulated concurrently with epigenetic reprogramming in PGCs (P < 0.001, hypergeometric test), with 45 genes commonly activated in both sexes ( Fig. 3a-c ). Considering their promoter methylation dynamics and the timing of their activation, we termed these 45 genes germline reprogramming-responsive (GRR) genes ( Fig. 3c) . Notably, GRR genes show significant enrichment for factors involved in gamete generation and meiosis, including Dazl, Sycp1-Sycp3, Mael, Hormad1, and Rad51c ( Fig. 3c and Supplementary Tables 5 and 7) .
Considering that GRR genes (n = 45) constituted less than 25% of the entire subset of HCP genes that undergo DNA demethylation (n = 226; Fig. 3a -c), DNA demethylation is probably an important factor for transcriptional activation of methylated HCPs, although other factors are also likely to be necessary. Indeed, GRR gene promoters showed both exceptionally high CpG density and levels of 5hmC compared to other methylated and demethylating HCPs (Extended Data Fig. 9a, b ). We also noted that, unusually for promoters, levels of 5hmC transiently increased at GRR gene promoters in PGCs immediately following the major wave of DNA demethylation (Extended Data Figs 3a, 9b). In addition, and in agreement with their high CpG density and levels of 5hmC 20, 21 , GRR gene promoters have been shown to be bound by TET1 in both mouse ES cells 21 and PGCs 9 (Fig. 3b ).
The observed binding of TET1 is functionally relevant, as the extent of GRR gene upregulation is considerably lower in Tet1 −/− PGCs than in wild-type PGCs (Fig. 4a , Extended Data Fig. 9c , Supplementary  Table 7 ). Although GRR gene promoters undergo normal DNA demethylation by E12.5 in the absence of TET1, they show slight hypermethylation later, in E14.5 Tet1 −/− PGCs (Fig. 4b ). However, this limited DNA hypermethylation shows only weak correlation with the decreased expression (Extended Data Fig. 9e ). Furthermore, lower expression of GRR genes in Tet1 −/− germ cells is already apparent at E12.5, in the absence of any methylation differences ( Fig. 4a, b , Extended Data Fig. 9e ), suggesting that TET1 is potentially acting as a transcriptional regulator outside its role in 5mC removal 21, 22 . In addition to GRR genes, transposable elements also become enriched in 5hmC during gonadal epigenetic reprogramming (Extended Data Figs 3b, 8). Alongside reduction in DNA methylation, some transposable elements show transcriptional activation concurrent with epigenetic reprogramming, especially from evolutionarily young retrotransposons (Extended Data Fig. 8 , Supplementary Table 9 ). Notably, the lack of TET1 appears also to reduce the extent of transcriptional activation of transposable elements that are normally activated (Extended Data Fig. 8 , Supplementary Table 9 ).
To further mechanistically probe the causal relationship between epigenetic reprogramming and GRR gene activation, we turned to an in vitro model. Serum-grown mouse ES cells represented an ideal system, as these cells are not germ line-restricted but have highly similar epigenetic modifications at GRR gene promoters to what is observed in vivo in pre-reprogramming gonadal PGCs (Extended Data Fig. 10a-d) . Consistent with what we observed in vivo, promoter DNA demethylation represents a dominant epigenetic reprogramming event for GRR gene activation in vitro. Dnmt1 −/− Dnmt3a −/− Dnmt3b −/− triple knockout (DNMT TKO) 23 mouse ES cells display increased expression of GRR genes ( Fig. 4c ). However, even in the complete absence of DNA methylation, this is crucially dependent on the presence of TET1 as Tet1 −/− DNMT TKO mouse ES cells fail to activate GRR genes as a group (Fig. 4c , Extended Data Fig. 9f ).
Although these in vitro observations clearly supported our in vivo data with respect to the roles of 5mC and TET1, the extent to which GRR genes were upregulated in DNMT TKO mouse ES cells ( Fig. 4c ) or in E10.5 PGCs that have undergone precocious DNA demethylation by conditional deletion of Dnmt1 (Dnmt1 CKO ) 24 (Extended Data Fig. 9d ) was relatively mild. We thus hypothesized that other factors, potentially including other epigenetic barriers, may regulate GRR gene expression. In this context, gonadal epigenetic reprogramming has previously been linked to the erasure of epigenetic information at various distinct levels 4, 25 , with removal of polycomb repressive complex 1 (PRC1) previously shown to coordinate the timing of meiosis initiation in DNA-demethylated E11.5/E12.5 PGCs 26 . Remarkably, genes that are aberrantly upregulated following PRC1 deletion in PGCs show a significant enrichment for GRR genes (Extended Data Fig. 11a ) and promoters of GRR genes in serum-grown mouse ES cells are enriched for RING1B binding and H2AK119ub (Extended Data Fig. 10a , e, f). In view of this, we simultaneously abolished both DNA methylation and PRC1 activity using highly specific chemical inhibition of PRC1 (using the inhibitor PRT4165 27 ) in DNMT TKO mouse ES cells to test the role of combined DNA methylation and PRC1 depletion on GRR gene regulation, thus mimicking gonadal epigenetic reprogramming. Culturing mouse ES cells with PRT4165 resulted in near complete inhibition of PRC1-mediated H2A ubiquitination after only 6 h of culture (Extended Data Fig. 11b ). Notably, Letter reSeArCH combined inhibition of 5mC-and PRC1-mediated repression resulted in the activation of 33 out of 45 GRR genes whereas 25 and 10 genes were activated after the individual inhibition of either 5mC-or PRC1-mediated repression, respectively ( Fig. 4d , Extended Data Fig. 11c ). These observations demonstrate that gonadal epigenetic reprogramming entails a composite erasure of epigenetic systems 4, 25 to potentiate the expression of GRR genes.
Our study has identified a set of GRR genes crucial for the correct progression of gametogenesis. These genes have unique promoter sequence characteristics, with high levels of both 5mC and 5hmC, and Letter reSeArCH are targets of TET1 and PRC1. We show that the combined loss of DNA methylation and PRC1 repression is uniquely required for GRR gene activation, with this epigenetically poised state further requiring TET1 to potentiate both full and efficient activation. TET1 appears to be particularly important in female PGCs 9 , which initiate meiotic prophase soon after completion of epigenetic reprogramming, thus imposing a requirement for the timely expression of these genes. Although we observed slight hypermethylation at GRR gene promoters in E14.5 Tet1 −/− PGCs, our study also clearly shows that TET1 stimulates transcription of GRR genes via a DNA demethylation-independent mechanism 21, 22 . In this context, previous studies have shown that TET1 recruits OGT to gene promoters 22 , thus facilitating deposition of H3K4me3 via SET1-COMPASS 28 , which leads to transcriptional activation. Furthermore, GRR gene promoters in mouse ES cells are marked by low but detectable H3K4me3, the levels of which are significantly decreased in the absence of TET1 without changes in DNA methylation ( Fig. 4b , Extended Data Fig. 10g ). Additionally, TET1 may also potentiate transcription through regulation of the levels of 5mC and 5hmC at non-promoter cis-active elements, such as enhancers. Last, but not least, our study shows that TET1 is not directly involved in initiation of global DNA demethylation during epigenetic reprogramming in gonadal PGCs; rather, we identify a critical role for TET1 in the subsequent removal of aberrant residual and/or de novo DNA methylation (Extended Data Fig. 12 ). This is reminiscent of the role of TET3-driven 5mC oxidation in protection against de novo DNA methy lation during zygotic DNA demethylation 29 , suggesting that global reprogramming events require efficient protection from de novo DNA methylation to stabilize the newly acquired epigenetic state after the removal of 5mC. Collectively, our results reinforce the idea that gonadal epigenetic reprogramming entails complex erasure of epigenetic information 4 and suggest that a central function of this process is to ensure the timely and efficient activation of GRR genes, thus enabling progression towards gametogenesis (Extended Data Fig. 12 ).
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Mice. All animal experiments were carried out under and in accordance with a UK Home Office Project Licence in a Home Office-designated facility. Except for direct comparisons with Tet1 −/− PGCs, wild-type PGCs were isolated from embryos produced by crossing outbred MF1 females with mixed background GOF18Δ PE-EGFP (ref. 5) transgenic males. The sex of embryos from E12.5 onwards was determined by visual inspection of the gonads. For the study of Tet1 −/− PGCs, the Tet1 knockout mouse strain (B6;129S4-Tet1 tm1.1Jae /J) 18 was purchased from the Jackson Laboratory and bred onto the GOF18Δ PE-EGFP transgenic mouse line. Wild-type and Tet1 −/− PGCs were isolated from embryos produced from crosses between Tet1-heterozygous GOF18Δ PE-EGFP-homozygous females and males. For genotyping of embryos produced by crossing Tet1-heterozygous GOF18Δ PE-EGFP-homozygous males and females, PCR was always carried out twice using two different sets of primers (see below) to confirm deletion of exon 4. The sex of the embryos from E12.5 onwards was determined by visual inspection of gonads and additionally confirmed by PCR for Sry. In all cases, matings were timed in such a way that appearance of a vaginal plug at noon was defined as E0.5.
The following genotyping primers were used in this study: TCAGGGAGCTCATG GAGACTA (Tet1 forward primer 1); AACTGATTCCCTTCGTGCAG (Tet1 forward primer 2); TTAAAGCATGGGTGGGAGTC (Tet1 reverse primer); TTGTCTAGAGAGCATGGAGGGCCATGTCAA (Sry forward primer); CCACTCCTCTGTGACACTTTAGCCCTCCGA (Sry reverse primer). PGC isolation by flow cytometry. PGC isolation was carried out as previously described 4 . In brief, the embryonic trunk (E10.5) or genital ridge (E11.5-E14.5) was digested at 37 °C for 3 min using 0.05% trypsin-EDTA (1× ) (Gibco) or TrypLE Express (Thermo Fisher Scientific). Enzymatic digestion was followed by neutralization with DMEM/F-12 (Gibco) containing 15% fetal bovine serum (Gibco) and manual dissociation by pipetting. Following centrifugation, cells were resuspended in DMEM/F-12 supplemented with hyaluronidase (300 μ g ml −1 ; Sigma), and a single cell suspension was generated by manual pipetting. Following centrifugation, cells were resuspended in ice-cold PBS supplemented with poly-vinyl alcohol (10 μ g ml −1 ) and EGTA (0.4 mg ml −1 , Sigma). GFP-positive cells were isolated using an Aria IIu (BD Bioscience) or Aria III (BD Bioscience) flow cytometer and sorted into ice-cold PBS supplemented with poly-vinyl alcohol (10 μ g ml −1 ) and EGTA (0.4 mg ml −1 , Sigma). Generation of Tet1 −/− DNMT TKO mouse ES cells. The Tet1 −/− DNMT TKO mouse ES cell line was generated by CRISPR-Cas9-mediated genome editing. pX330 (Addgene, 42230) with a short guide RNA targeting Tet1 31 (GGCTGCTGTCAGGGAGCTCA) was co-transfected with a reporter GFP plasmid into 5 × 10 6 DNMT TKO mouse ES cells 23 using Lipofectamine 3000. On the next day, GFP positive cells were sorted using fluorescence activated cell sorting (FACS) (BD Bioscience FACS Aria III) to a 96-well plate. Cells were cultured for a week and then frozen down before extraction of genomic DNA. Colonies were screened for mutations using a surveyor assay (Surveyor Mutation Detection Kit from IDT, and Taq DNA polymerase from Qiagen). Selected clones of Tet1 −/− DNMT TKO mouse ES cells were further analysed by genotype sequencing, which confirmed the presence of a frameshift mutation. Loss of Tet1 was verified by RNA-seq and western blot. The following primers were used for genotype sequencing and surveyor assay: 5′ TTGTTCTCTCCTCTGACTGC 3′ and 5′ TGATTGATCAAATAGGCCTGC 3′ . Mouse ES cell culture. J1 (wild type), DNMT TKO 23 and Tet1 −/− DNMT TKO mouse ES cells were cultured in FCS/leukaemia inhibitory factor (LIF) medium without feeders on 0.1% gelatin. FCS/LIF medium consists of GMEM (Gibco) supplemented with 10% FCS, 0.1 mM MEM nonessential amino acids, 2 mM l-glutamine, 1 mM sodium pyruvate, 0.1 mM 2-mercaptoethanol and mouse LIF (ESGRO, Millipore). For inhibitor experiments, mouse ES cells were plated at a density of 1.5 × 10 4 cells per cm 2 and left overnight. On the next morning, medium was exchanged for FCS/LIF medium containing either 50 μ M PRC1 inhibitor PRT4165 27 or DMSO control and cells were pelleted at the indicated time for analysis. Aba-seq library preparation. Total DNA was isolated from 10,000 sorted PGCs using the QIAamp DNA Micro Kit (Qiagen). Aba-seq libraries for 5hmC profiling were constructed as previously described 15 . In brief, genomic DNA was glucosylated and then digested using AbaSI enzyme (NEB). Biotinylated P1 adapters were ligated onto the AbaSI-digested DNA, which was then fragmented using a Covaris S2 sonicator (Covaris), following the manufacturer's instructions. Sheared P1-ligated DNA was then captured by mixing with Dynabeads MyOne Streptavidin C1 beads (Life Technologies) according to the manufacturer's specifications. End repair and dA-tailing were carried out on the beads by using the NEBNext End Repair Module (NEB) and the NEBNext dA-tailing Module (NEB) at 20 °C and 37 °C, respectively, for 30 min. P2 adapters were ligated to the random sheared ends of the dA-tailed DNA. Finally, the entire DNA was amplified using Phusion DNA polymerase (NEB) with the addition of 300 nM forward primer (PCR_I) and 300 nM reverse primers (PCR_IIpe) for 16 cycles. The libraries were purified using AMPure XP beads (Beckman-Coulter) and sequenced on the Illumina HiSeq 2000 instrument. WGBS library preparation. Total DNA was isolated from 10,000 sorted PGCs using the QIAamp DNA Micro Kit (Qiagen). In some cases, unmethylated λ -phage DNA (Promega) was spiked in following DNA isolation to assess bisulfite conversion rate. DNA was fragmented using a Covaris S2 sonicator (Covaris), following the manufacturer's instructions. Libraries were prepared following the NEBNext Library Prep protocol, with methylated adaptors and the following modifications. First, bisulfite conversion was carried out after adaptor ligation using the Imprint Modification Kit (Sigma). Second, PCR enrichment was carried out for 16 cycles using the NEXTflex Bisulfite-Seq Kit for Illumina Sequencing (Bioo Scientific) master mix and the NEBNext Library Prep universal and index primers (NEB). The libraries were purified using AMPure XP beads (Beckman-Coulter). Libraries were sequenced on the Illumina HiSeq 2000 or 2500 instrument. RRBS library preparation. Total DNA from FACS-sorted PGCs isolated from individual Tet1 −/− or wild-type embryos was extracted using the ZR-Duet DNA-RNA MiniPrep kit (Zymo), and DNA from between two and five embryos (equivalent to 1,000 to 8,000 cells) of the same genotype, stage and sex was pooled and concentrated to 26 μ l final volume using the Savant SpeedVac Concentrator (Thermo Fisher Scientific) according to the manufacturer's instructions. Genomic DNA was digested using 20 U of MspI enzyme (NEB) in NEB buffer 2 at 37 °C for 3 h, and digested DNA was purified using AMPure XP beads (Beckman-Coulter). Libraries were made following the NEBNext Ultra DNA Library Prep protocol with methylated adaptors and the following modifications. First, bisulfite conversion was carried out after adaptor ligation using the Imprint Modification Kit (Sigma). Second, PCR enrichment was carried out for 18 cycles using the KAPA Uracil + DNA polymerase master mix (KAPA Biosystems) and the NEBNext Library Prep universal and index primers (NEB). The libraries were purified using AMPure XP beads (Beckman-Coulter). Pooled libraries were sequenced on the Illumina HiSeq 2500 instrument, using the 'dark sequencing' protocol, as previously described 32 . RNA-seq library preparation. For the study of Tet1 −/− PGCs, total RNA from sorted PGCs isolated from individual Tet1 −/− or wild-type embryos was extracted using ZR-Duet DNA-RNA MiniPrep kit (Zymo), and RNA from between two and six embryos (equivalent to 1,000 to 8,000 cells) of the same genotype, stage and sex was pooled and concentrated to 6 μ l final volume using the RNA Clean and Concentrator 5 kit (Zymo). For the study of wild-type PGCs isolated from embryos produced by crossing MF1 females with GOF18Δ PE-EGFP males, total RNA from 600-1,000 sorted E10.5 PGCs was isolated using the Nucleospin RNA XS kit (Macherey-Nagel). cDNA synthesis and amplification (15 cycles) was performed with the SMARTer Ultra Low Input RNA kit (Clontech) using between 100 pg and 3 ng total RNA, according to the manufacturer's instructions. The amplified cDNA was fragmented using a Covaris S2 sonicator (Covaris), following the manufacturer's instructions. Sheared cDNA was converted to sequencing libraries using the NEBNext DNA Library Prep kit (NEB), following the manufacturer's instructions and using 15 cycles of amplification. For the study of mouse ES cells, total RNA was isolated using ZR-Duet DNA-RNA MiniPrep kit (Zymo). cDNA synthesis and library preparation were performed starting with 500 ng total RNA using the NEBNext Ultra Library Prep Kit (NEB) and the NEBNext Poly(A) mRNA Magnetic Isolation Module (NEB) according to the manufacturer's instrcutions. All libraries were purified by AMPure XP beads (Beckman-Coulter) and sequenced on the Illumina HiSeq 2500 instrument. WGBS and Tet-assisted bisulfite sequencing (TAB-seq) alignment and downstream analysis. Raw reads were first trimmed using Trim Galore (v.0.3.1) with the '--paired' and '--trim1' options. Alignments were carried out to the mouse genome (mm9, NCBI build 37) using Bismark (v.0.13.0) with the '-n 1' parameter; where appropriate, the λ phage genome was added as an extra chromosome. Aligned reads were deduplicated with deduplicate_bismark. Where appropriate, the bisulfite conversion rate was computed using reads aligned to the λ phage genome and using the to-mr script ('-m bismark' parameters) and bsrate script ('-N' parameter) of Methpipe (v.3.3.1). CpG-methylation calls were extracted from the deduplicated mapping output using the Bismark methylation extractor. The number of methylated and unmethylated cytosines in a CpG context was extracted using bismark2bedGraph and coverage2cytosine. Symmetric CpGs were merged using a custom R script. For all downstream analysis, only symmetric CpGs with a minimum of 8× coverage were used. All WGBS analysis was carried out on data from merged biological replicates. For assessing DNA modification levels at specific repetitive elements, Bismark (v.0.14.4) was used to map all reads from each dataset against consensus sequences constructed from Repbase with the '-n 1' parameter set. CpG-methylation calls were extracted from the mapping output using the Bismark methylation extractor (v.0.14.4).
The mapBed function of BEDtools (v.2.24.0) was used to compute the combined level of 5mC and 5hmC for the following genomic features: 1) all 2-kb windows Letter reSeArCH (containing a minimum of four symmetric CpGs); 2) gene promoters (defined as Ensembl 67 gene start sites − 1 kb/+ 500 bp); 3) gene bodies (defined as the region contained within Ensembl 67 gene start and gene end sites); 4) putative active enhancers in day 6 PGC-like cells 33 ; 5) ICRs; 6) CpG islands (UCSC); 7) intergenic regions. For metagene plots, a genomic feature was divided into equally sized bins using BEDtools (v.2.24.0), including: 1) gene bodies (defined as the region contained within Ensembl 67 gene start and gene end sites) ± 0.5 × gene body length (100 bins); 2) putative active enhancers in day 6 PGC-like cells 33 ± 1 × putative active enhancer length (90 bins); and 3) CpG islands (UCSC) ± 1 × CpG island length (90 bins). In all cases, the combined level of 5mC and 5hmC was expressed as the mean of individual CpG sites.
For k-means clustering of the combined mean levels of 5mC and 5hmC, HCPs, ICPs and LCPs were defined using previously published parameters 19, 34 . In brief, LCPs contain no 500-bp window with a CpG ratio > 0.45; HCPs contain at least one 500-bp window with a CpG ratio > 0.65 and GC content > 55%; ICPs do not meet the previous criteria.
To determine locus-specific methylation levels in wild-type mouse ES cells grown in serum-containing medium, raw WGBS reads were downloaded from GSE48519 30 and processed as above. TAB-seq reads for E14 mouse ES cells were downloaded from GSE36173 35 and processed as above, with the exception that only symmetric CpGs with a minimum of 12× coverage were used. Aba-seq alignment and downstream analysis. For the uniquely mapped part of the genome, Aba-seq reads were processed as previously described 15 . In brief, raw sequencing reads were trimmed to remove adaptor sequences and low quality bases using Trim Galore. The trimmed reads were mapped to the mouse genome (mm9, NCBI build 37) using Bowtie (v.0.12.8) with parameters '-n 1 -l 25 --best --strata -m 1' . Detection of 5hmC was based on the recognition sequence and cleavage pattern of the AbaSI enzyme (5′ CN [11] [12] [13] ↓ N 9-10 G 3′ /3′ GN 9-10 ↓ N 11-13 C 5′ ) using custom Perl scripts. For assessing the relative enrichment of 5hmC at repetitive elements and non-repetitive elements, Aba-seq alignments were divided into two groups: unique (single best alignment) and ambiguous (map to multiple locations with equal alignment score). Both groups were then mapped separately to the repetitive elements defined by the RepeatMasker track of mm9 (UCSC Genome Browser). For comparison with the levels of 5hmC in mouse ES cells, Aba-seq reads were downloaded from GSE42898 15 and aligned in the same way.
To quantify the relative levels of 5hmC at symmetric CpGs in the uniquely mapped part of the genome, the number of counts per symmetric CpG for a given sample were normalized to the combined number of uniquely mapped and ambiguously mapped reads for a given library, and then further multiplied by a stage-specific normalization factor that was based on the mean level of 5hmC for each stage as computed by LC-MS/MS(E14 ESC = 1.64; E10.5 = 1.0; E11.5 = 1.13; E12.5F = 0.76; E12.5M = 1.0). All symmetric CpGs falling within genomic intervals blacklisted by the mouse (mm9) ENCODE project were excluded from all further downstream analysis. Unless stated otherwise, all Aba-seq analysis was carried out on data from merged biological replicates.
The mapBed function of BEDtools (v.2.24.0) was used to compute the level of 5hmC for the same genomic features as carried out with WGBS datasets (see above). In all cases, the level of 5hmC was expressed as the mean of individual CpG sites.
To identify 5hmC-enriched or -depleted regions in E10.5 and E11.5 PGCs, the mm9 genome was first divided into 2-kb windows (minimum four symmetric CpGs) and the mean level of 5hmC for each window was computed using BEDtools (v.2.24.0). To determine the significance of 5hmC enrichment in each 2-kb window, upper-tail (to determine 5hmC enriched regions) or lower-tail (to determine 5hmC depleted regions) Poisson probability P values were computed using ppois(x, λ), where x is the observed 5hmC mean value for each 2-kb window and λ is the mean of 5hmC mean values for all 2-kb windows at E10.5. Benjamini-Hochberg correction was then applied to correct for multiple testing, giving a final adjusted upper-tail and lower-tail P value for each 2-kb window. Windows with an adjusted upper-tail P < 0.05 were considered relatively enriched for 5hmC and windows with adjusted lower-tail P < 0.05 were considered relatively depleted for 5hmC.
For assessing relative enrichment of 5hmC at specific repetitive elements, Bowtie was used to map all reads from each dataset against consensus sequences constructed from Repbase with parameters '-n 1 -M 1 --strata --best' . The number of reads mapped to each sequence within a given sample was first normalized to the library size of that particular sample, and then normalized to both a stage-specific normalization factor that was based on the mean level of 5hmC for each stage as computed by LC-MS/MS(E10.5 = 1.0; E11.5 = 1.13; E12.5F = 0.76; E12.5M = 1.0) and the mean proportion of reads mapped to a given sequence in E10.5 PGCs. RRBS alignment and downstream analysis. Raw RRBS reads were first trimmed using Trim Galore (v.0.3.1) with the '--rrbs' parameter. Alignments were carried out to the mouse genome (mm9, NCBI build 37) using Bismark (v.0.13.0) with the '-n 1' parameter. CpG-methylation calls were extracted from the mapping output using the Bismark methylation extractor (v.0.13.0). The number of methylated and unmethylated cytosines in a CpG context was extracted using bismark2bedGraph.
RnBeads (v.1.0.0) and RnBeads.mm9 (v.0.99.0) ('filtering.missing.value.quantile' set to 0.95 and 'filtering.missing.coverage.threshold' set to 8) were used to identify differentially methylated regions between the two test groups for the following genomic features: 1) all 2-kb windows (containing a minimum of four symmetric CpGs); 2) gene promoters (defined as Ensembl 67 gene start sites − 1 kb/+ 500 bp); and 3) ICRs (mm9 genome). The following data were extracted from the output of RnBeads: 1) the mean methylation level for each group (that is, stage, sex and/or genotype) for each commonly covered test region; 2) the difference in methylation means between two groups for each commonly covered test region; and 3) the P value representing the significance of the difference in methylation means between two groups for each commonly covered test region. Differentially methylated regions were identified as regions with P < 0.05 and a difference in methylation means between two groups greater than 10%.
For assessing DNA modification levels at specific repetitive elements, Bismark (v.0.14.4) was used to map all reads from each dataset against consensus sequences constructed from Repbase with the '-n 1' parameter set. CpG-methylation calls were extracted from the mapping output using the Bismark methylation extractor (v.0.14.4). The number of methylated and unmethylated cytosines in a CpG context were extracted using bismark2bedGraph and coverage2cytosine. Differentially methylated consensus repeats were identified as regions with a P < 0.05 (as computed by two-sided Student's t-test) and a difference in methylation means between two groups greater than 10%. Hydroxymethylated-DNA immunoprecipitation alignment and downstream analysis. Raw hydroxymethylated-DNA immunoprecipitation (hMeDIP) sequencing and input reads for E14 mouse ES cells were downloaded from GSE28500 36 and aligned to the mouse genome (mm9, NCBI build 37) using Bowtie (v.0.12.8) with parameters '-n 2 -l 25 -m 1' . BEDtools multicov was used to identify the number of hMeDIP and input reads overlapping each 2-kb window (containing a minimum of four symmetric CpGs). Final levels of 5hmC for each 2-kb window were determined by first normalizing the number of overlapping hMeDIP reads (normalized to library size) by the number of overlapping input reads (normalized to library size) and then dividing this value by the number of symmetric CpGs contained within the 2-kb window. Chromatin immunoprecipitation sequencing alignment and downstream analysis. For putative active enhancer calling, raw chromatin immunoprecipitation sequencing (ChIP-seq) reads for H3K4me3, H3K27me3 and H3K27Ac in day 6 PGC-like cells were downloaded from GSE60204 33 and raw ChIP-seq reads for H3K4me3, H3K27me3, H3K4me1 and H3K27Ac in wild-type mouse ES cells were downloaded from GSE48519 30 . Reads were aligned to the mouse genome (mm9, NCBI build 37) with Bowtie (v.0.12.8 or v.1.0.0) with parameters '-n 2 -l 25 -m 1' and '-C' where appropriate. Subsequent ChIP-seq analysis was carried out on data from merged biological replicates. To identify putative active enhancers, we first generated an eight-state chromatin model using ChromHMM. Putative active enhancers were defined as all regions not overlapping any potential promoter regions (Ensembl 67 gene start sites − 1 kb/+ 500 bp) and contained within the (H3K27Ac + /H3K4me3 − /H3K27me3 − ) chromatin state in day 6 PGC-like cells or (H3K4me1 + /H3K27Ac + /H3K4me3 − /H3K27me3 − ) in wild-type mouse ES cells.
For analysis of epigenetic modifications and modifiers around transcription start sites (Ensembl 67): raw ChIP-seq reads for: TET1 binding in wild-type serumgrown mouse ES cells were downloaded from GSE24843 21 ; H2AK119ub1 levels in wild-type serum-grown mouse ES cells were downloaded from GSE34520 37 ; RING1B binding in wild-type serum-grown mouse ES cells were downloaded from ERP005575 38 ; and for H3K4me3 in wild-type and Tet1 −/− serum-grown mouse ES cells were downloaded from GSE48519 30 . Reads were aligned to the mouse genome (mm9, NCBI build 37) with Bowtie (v.0.12.8 or v.1.0.0) with parameters '-n 2 -l 25 -m 1' . Subsequent ChIP-seq analysis was carried out on data from merged biological replicates. For computing the ChIP-seq signal around transcription start sites, the genomic interval around the Ensembl 67 gene transcription start sites (± 5 kb or 2 kb) was divided into 100 (or 40) equally sized bins using BEDtools makewindows. BEDtools multicov was then used to compute the number of test and control reads overlapping each bin. The total numbers of test and control reads per bin for each sample were normalized to the appropriate library size, and fold enrichment for each bin was determined by dividing the number of normalized ChIP-seq test sample reads by the number of normalized ChIP-seq control sample reads. For computing ChIP-seq signal at gene promoters, the genomic interval around the Ensembl 67 gene start sites + 500 bp/− 1 kb was used to compute the number of test and control reads overlapping each region. RNA-seq alignment and downstream analysis. For the study of Tet1 −/− and wild-type Tet1 PGCs, Illumina and SMART-seq adapters from the sequencing reads were first trimmed using Trimmomatic. For other RNA-seq libraries, fastq Letter reSeArCH files generated from output of next generation sequencing were used directly for alignment. RNA-seq reads were aligned to the mouse genome (mm9, NCBI build 37) with Bowtie (v.0.12.8) and Tophat (v.2.0.2) with options '-N 2 --b2-verysensitive --b2-L 25' . Annotations from Ensembl Gene version 67 were used as the gene model with Tophat. Read counts per annotated gene were computed using HTSeq (v.0.5.3p9) and the expression of each gene was quantified by computing the FPKM using a custom R script. Genes were assigned to an expression-level bin based on the mean FPKM values of the two biological replicates. Differential expression analysis was performed using DESeq2 (v.1.6.3), and genes with an adjusted P < 0.05 were considered to be differentially expressed. For determining gene expression levels in wild-type and Dnmt1 CKO and matched wild-type E10.5 PGCs, raw RNA-seq reads were downloaded from GSE74938 24 and processed as described above.
HCPs that were methylated and demethylated in PGCs during epigenetic reprogramming (cluster 3, Fig. 3a) were ranked on the basis of the significance of activation (α) between gene expression in E10.5 and E14.5 PGCs (Fig. 3b ). In the case where β represents the directionality of fold change (that is, if log 2 (fold change) < 0, β = − 1; else β = 1) and γ represents the adjusted P value as computed by DESeq2, α = β × (1 − γ). For comparing expression levels of the GRR gene set in 1) wild-type, DNMT TKO, and Tet1 −/− DNMT TKO mouse ES cells (Fig. 4c) ; 2) in wild-type + 6 h DMSO treatment, DNMT TKO + 6 h DMSO treatment, wildtype + 6 h PRT4165 treatment, DNMT TKO + 6 h PRT4165 treatment (Fig. 4d) ; 3) Tet1 −/− E14.5 PGCs against wild-type E14.5 PGCs (Extended Data Fig. 9c ); or 3) Dnmt1 CKO E10.5 PGCs against wild-type E10.5 PGCs (Extended Data Fig. 9d ) pairwise differential expression analysis was initially carried out by DESeq2 for each condition against each other condition. For each pairwise differential expression test, each gene was assigned a statistic α, where if β represents the log 2 (fold change) and γ represents the adjusted P value as computed by DESeq2, α = β × (1 − γ). The gene list ranked on the basis of α was subsequently used for GSEA for testing general up-or downregulation of the combined GRR gene sets and GSEA hallmark gene sets. GSEA FWER-adjusted P values were subsequently used. For overlap between GRR genes and genes repressed by PRC1 in PGCs (Extended Data Fig. 11a) , the list of genes labelled as upregulated in E11.5 and/or E12.5 PRC1 conditional knockout (PRC1 CKO) PGCs was downloaded from ref. 26. For classification of GRR genes (Extended Data Fig. 10 , Supplementary Table 5 ), pairwise differential expression analysis was first carried out. 5mC-reprogrammingdependent GRR genes were defined as genes that were: 1) upregulated in DNMT TKO versus wild type, DNMT TKO + PRC1 inhibitor versus wild type, and DNMT TKO + PRC1 inhibitor versus wild type + PRC1 inhibitor; and 2) not upregulated in wild type + PRC1 inhibitor versus wild type. PRC1-reprogramming-dependent GRR genes were defined as genes that were: 1) upregulated in wild type + PRC1 inhibitor versus wild type, DNMT TKO + PRC1 inhibitor versus wild type, and DNMT TKO + PRC1 inhibitor versus DNMT TKO; and 2) not upregulated in DNMT TKO versus wild type. 5mC/PRC1-reprogramming-dependent GRR genes were defined as genes that were either: 1) upregulated in wild type + PRC1 inhibitor versus wild type, DNMT TKO versus wild type, DNMT TKO + PRC1 inhibitor versus wild type, DNMT TKO + PRC1 inhibitor versus DNMT TKO, and DNMT TKO + PRC1 inhibitor versus wild type + PRC1 inhibitor; or 2) upregulated in DNMT TKO + PRC1 inhibitor versus wild type, DNMT TKO + PRC1 inhibitor versus DNMT TKO, and DNMT TKO + PRC1 inhibitor versus wild type + PRC1 inhibitor, and not upregulated in wild type + PRC1 inhibitor versus wild type and DNMT TKO versus wild type. 5mC/PRC1-reprogramming-independent or -insufficient GRR genes were defined as genes that were not upregulated in DNMT TKO versus wild type, DNMT TKO + PRC1 inhibitor versus wild type, DNMT TKO + PRC1 inhibitor versus wild type + PRC1 inhibitor, and wild type + PRC1 inhibitor versus wild type. Genes that did not fall into one of these four classes were described as low confidence classification genes. Detection of TET1, 5mC and 5hmC by immunofluorescence. The embryonic trunk (E10.5) or genital ridge (E12.5/E13.5) was first fixed in 2% PFA (in PBS) for 30 min at 4 °C. Following fixation, tissue was washed in PBS three times for 10 min and then incubated in 15% sucrose in PBS overnight. After rinsing with 1% BSA in PBS the following day, the tissue was embedded in OCT Embedding Matrix (Thermo Fisher Scientific Raymond Lamb) and frozen using liquid nitrogen. Samples were subsequently stored at − 80 °C. A Leica CM 1950 cryostat was used to cut 10 μ m sections from the frozen embedded tissue. Sections were settled on poly-lysine slides (Thermo Fisher Scientific) and post-fixed with 2% PFA in PBS for 3 min.
For detection of TET1, sections were washed three times for 5 min with PBS. After incubating for 30 min at room temperature in 1% BSA in PBS containing 0.1% Triton X-100, the sections were incubated with the listed primary antibodies at 4 °C overnight in the same buffer. Sections were subsequently washed three times in 1% BSA in PBS containing 0.1% Triton X-100 for 5 min and incubated with secondary antibodies in the same buffer for 1 h in the dark at room temperature. After secondary antibody incubation samples were washed three times in PBS for 5 min. DNA was then stained with DAPI (100 ng ml −1 ). After a final wash in PBS for 10 min, the sections were mounted with Vectashield (Vector Laboratories).
For detection of 5hmC and 5mC, sections were washed three times for 5 min with PBS. Post-fixed sections were first permeabilized for 30 min with 0.5% Triton X-100 (in 1% BSA in PBS), and subsequently treated with RNase A (10 mg ml −1 ; Roche) in 1% BSA in PBS for 1 h at 37 °C. After three 5 min washes with PBS, sections were incubated with 4N HCl for 10-20 min at 37 °C to denature genomic DNA and then washed three times for 10 min with PBS. After incubating for 30 min at room temperature in 1% BSA in PBS containing 0.1% Triton X-100, the sections were incubated with the listed primary antibodies at 4 °C overnight in the same buffer. Sections were subsequently washed three times in 1% BSA in PBS containing 0.1% Triton X-100 for 5 min and incubated with secondary antibodies in the same buffer for 1 h in the dark at room temperature. After secondary antibody incubation samples were washed three times in PBS for 5 min. DNA was then stained with propidium iodide (0.25 mg ml −1 ). After a final wash in PBS for 10 min, the sections were mounted with Vectashield (Vector Laboratories).
The following primary antibodies were used in this study: anti-SSEA1 (gift from P. Beverly via G. Durcova Hills); anti-MVH (Abcam 27591 or Abcam 13840); anti-5hmC (Active motif 39791), anti-5mC (Diagenode C15200081-100); anti-TET1 (GeneTex GTX125888); anti-GFP (Abcam 5450). The following secondary antibodies were used in this study: Alexa Fluor 647 goat anti-mouse IgM (Invitrogen A21238); Alexa Fluor 488 goat anti-rabbit IgG (Invitrogen A11008); Alexa Fluor 405 goat anti-mouse IgG 1:300 (Invitrogen A31553); Alexa Fluor 488 goat antimouse IgG 1:300 (Invitrogen A11001); Alexa Fluor 405 goat anti-rabbit IgG 1:300 (Invitrogen A31556); Alexa Fluor 568 donkey anti-rabbit IgG (Invitrogen A10042); Alexa Fluor 488 donkey anti-goat IgG (Invitrogen A11055). Locus-specific bisulfite sequencing. Bisulfite treatment of genomic DNA was carried out using the Imprint DNA modification kit (Sigma). The following primers were used for the semi-nested amplification of the Dazl promoter: forward 1: GATTT TTGTTATTTTTTAGTTTTTTTAGGAT; forward 2: TTTATTTAAGTTATTAT TTTAAAAATGGTATT; reverse: AGAAACAAGCTAGGCCAGCTGAGAG AATTCT. The following primers were used for the semi-nested amplification of the IG-DMR ICR: forward 1: GTGTTAAGGTATATTATGTTAGTGTTAGG; forward 2: ATATTATGTTAGTGTTAGGAAGGATTGTG; reverse: TACAACC CTTCCCTCACTCCAAAAATT. The following primers were used for the nested amplification of the Peg3 ICR: forward 1: TTTTTAGATTTTGTTTGGGGG TTTTTAATA; forward 2: TTGATAATAGTAGTTTGATTGGTAGGGTGT; reverse 1: AATCCCTATCACCTAAATAACATCCCTACA; reverse 2: ATCTACAACCTTATCAATTACCCTTAAAAA. Methylation levels were assessed using QUMA, applying default settings with duplicate bisulfite sequences excluded. Mass spectrometry. Genomic DNA from between 100 and 2,000 FACS-sorted PGCs was extracted using ZR-Duet DNA/RNA Miniprep kit (Zymo Reasearch) following the manufacturer's instructions and eluted in LC-MS grade water. DNA was digested to nucleosides using a digestion enzyme mix provided by NEB. A dilution series made with known amounts of synthetic nucleosides and the digested DNA was spiked with a similar amount of isotope-labelled nucleosides (provided by T. Carell) and separated on an Agilent RRHD Eclipse Plus C18 2.1 × 100 mm 1.8 μ m column using the UHPLC 1290 system (Agilent) and an Agilent 6490 triple quadrupole mass spectrometer as previously described 29 . To calculate the quantity of individual nucleosides, standard curves representing the ratio of unlabelled over isotope-labelled nucleosides were generated and used to convert the peak-area values to corresponding quantities. The threshold for quantification is a signal-to-noise above ten (calculated with a peak-to-peak method). Western blotting. Mouse ES cells were lysed by sonication in RIPA buffer (150 mM sodium chloride, 1.0% Triton X-100, 0.5% sodium deoxychlorate, 0.1% sodium dodecylsulfate, 50 mM Tris pH 8.0) and protease-inhibitor cocktail (Roche, 11 697 498 001). Cell debris was removed by centrifugation at 14,000g for 5 min at 4 °C. Protein levels were quantified using the BCA protein assay (Thermo Fisher Scientific, 23227). Each protein extract (2 μ g for H2A and H2Aub or 20 μ g for TET1) was loaded onto a 15% or 8% SDS polyacrylamide gel and transferred to a PVDF membrane after electrophoresis. Membranes were blocked with 5% BSA for 1 h and then incubated overnight at 4 °C with primary antibodies at the following dilutions: anti-H2A antibody (Abcam, 18255) 1:2,000; anti-ubiquityl H2A antibody (Cell Signalling 8240) 1:2,000; anti-TET1 antibody (N terminus) (GeneTex GTX125888) 1:1,000; anti-lamin B antibody (C20) (Santa Cruz Biotechnologies, sc-6216) 1:10,000. Donkey anti-rabbit IgG-HRP (Santa Cruz Biotechnologies, sc-2077) or donkey anti-goat IgG-HRP (Santa Cruz Biotechnologies, sc-2056) secondary antibodies were then incubated for 1h at room temperature. Blots were developed using Luminata Crescendo Western HRP substrate (EMD Milipore).
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Statistics and reproducibility. No statistical methods were used to predetermine sample size, the experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. All statistical tests are clearly described in the figure legends and/or in the Methods section, and exact P values values or adjusted P values are given where possible.
For WGBS experiments (Fig. 3a, b , and Extended Data Figs 1a, 2c-e, 3a, b, 4, 7, 8), data are derived from cells from either n = 1 (E10.5 PGC sample) or n = 2 (all other samples) biological replicates and each replicate was obtained from pooled embryos (E10.5, n = 39 embryos from 4 litters; E11.5, n = 8 embryos from 1 litter; E12.5M/F, n = 4 embryos from 1 litter). For Aba-seq experiments (Figs 1d, 3a, b , and Extended Data Figs 1c-e, 2a-f, 3a, b, 4, 7, 8, 9b ), data are derived from cells from n = 2 biological replicates and each replicate was obtained from pooled embryos (E10.5, n = 40 embryos from 4 litters; E11.5, n = 8 embryos from 1 litter; E12.5M/F, n = 4 embryos from 1 litter). For RNA-seq of mouse ES cells, samples are derived from n = 2 biological replicates corresponding to n = 2 independently cultured samples from one cell line. Complete details for PGC LC-MS, RNA-seq and RRBS data are reported in Supplementary Table 6 including the numbers of embryos and litters from which samples were derived. Western blots (Extended Data Figs 9f, 11b) were performed three times with similar results, and representative blots are shown. All immunostaining experiments (Figs 1e, 2a , b, Extended Data Fig. 6b ) were performed twice with similar results and representative images are shown. Traditional bisulfite sequencing (Extended Data Fig. 6f, g) was carried out twice and a representative methylation profile is shown. For analysis of previously published WGBS (Extended Data Fig. 10a, b ), TAB-seq (Extended Data Fig. 1c-e ), Aba-seq (Extended Data Figs 1c-e, 2b, 10a, 10c ) and ChIP-seq ( Fig. 3b , Extended Data Figs 10a, 10c-g) datasets from mouse ES cells (see Methods for accession numbers), other than the H2Aub ChIP-seq dataset in which n = 1, biological replicates were analysed both combined (shown) and separately (not shown) to ensure reproducibility of analysis. Data availability. Sequencing data reported in this paper are tabulated in Supplementary Tables 1-4 
Step 1 -Combined (5mC + 5hmC) starting level (WGBS)
Step 
5-methylcytosine unmodi ed cytosine 5-hydroxymethylcytosine 5-carboxycytosine
Step 2 -High combined (5mC + 5hmC) level (WGBS) High (5hmC)/(5mC + 5hmC) level (i.e. 5hmC enrichment)
Step 3 -Extensive decrease in combined (5mC + 5hmC) level (WGBS) Low 5hmC/(5mC + 5hmC) level (i.e. 5hmC enrichment)
Step 1 -High combined (5mC + 5hmC) level (WGBS)
Step 2 -High total 5hmC level High combined (5mC + 5hmC) level (WGBS)
Step 3 -Extensive decrease in combined (5mC + 5hmC) level (WGBS) High 5hmC level
Step 3 -Extensive decrease in combined (5mC + 5hmC) level (WGBS) High 5hmC/(5mC + 5hmC) level (i.e. 5hmC enrichment)
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Extended Data Figure 5 | Suggested models implicating 5mC oxidation in DNA demethylation of gonadal PGCs. a, A model of oxidation followed by passive dilution predicts a positive correlation between the extent to which the combined levels of 5mC and 5hmC decrease between two stages (as determined by WGBS) and the total level of 5hmC at both the stage immediately preceding and following the decrease. b, A model implicating 5mC oxidation in triggering DNA demethylation via an active mechanism predicts a positive correlation between the extent to which the combined levels of 5mC and 5hmC decrease between two stages (as determined by WGBS) and the relative levels of 5hmC in the stage immediately preceding this decrease, as further oxidation of 5hmC to 5-formylcytosine (5fC) is the rate-limiting step in the full oxidation of 5mC to 5-carboxylcytosine (5caC) (ref. 39) . c, A model implicating oxidation of 5mC in safeguarding DNA hypomethylation following the major wave of DNA demethylation predicts that regions where the majority of DNA methylation has been lost between two stages (that is, those that are newly hypomethylated) will have high relative levels of 5hmC in the stage immediately after the major wave of DNA demethylation in order to remove residual methylation and/or aberrant de novo methylation. Thus, a limited correlation between the extent to which the combined levels of 5mC and 5hmC decrease between two stages (as determined by WGBS) and the relative levels of 5hmC in the stage immediately following this decrease may also be seen. Adjusted P values for differential repeat expression analysis between E14.5 wild-type and Tet1 −/− PGCs are based on Sleuth software.
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Extended Data Figure 10 | Epigenetic characterization of GRR gene promoters in mouse ES cells. a, Genomic sequences centred on transcription start sites of GRR genes, non-GRR genes activated in both male and female PGCs between E10.5 and E14.5, and non-GRR methylated and demethylated HCP genes in wild-type mouse ES cells grown in serum-containing medium. Each horizontal line represents one gene; the intensity of red indicates the relative enrichment for the feature shown at the top of each column. The transcription start site and sequences 5 kb upstream and downstream of the transcription start site are shown. b-f, Box plots depicting the combined levels of 5mC and 5hmC (ascertained using WGBS) 30 (b); levels of 5hmC (ascertained using Abaseq) 15 (c); levels of TET1 (ChIP-seq data) 21 (d); levels of RING1B (ChIPseq data) 38 (e) and levels of H2Aub (ChIP-seq data) 37 (f) at the promoters of GRR genes and of other relevant gene sets in wild-type mouse ES cells grown in serum-containing media. For all box plots, the upper and lower hinges correspond to the first and third quartiles, the centre line corresponds to the median, and the maxima and minima correspond to the highest and lowest value within 1.5 × the inter-quartile range, respectively. P values are based on a two-sided Wilcoxon test. g, Metagene plot depicting median levels of H3K4me3 (ChIP-seq data) 30 around the transcription start sites of GRR genes (left) and non-GRR HCP genes that are also initially methlylated and subsequently demethylated during PGC reprogramming (right) in wild-type and Tet1 −/− mouse ES cells grown in serum-containing medium. P values are based on a paired two-sided Wilcoxon test for the promoter (− 1 kb/+ 500 bp) region. Corresponding author(s): Petra Hajkova Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Please do not complete any field with "not applicable" or n/a. Refer to the help text for what text to use if an item is not relevant to your study. For final submission: please carefully check your responses for accuracy; you will not be able to make changes later.
Experimental design 1. Sample size
Describe how sample size was determined.
No statistical methods were used to predetermine sample sizes.
Data exclusions
Describe any data exclusions.
No data was excluded from the analysis.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
Experimental findings were reliably reproduced. Experimental replication was attempted for all datasets/figures shown, with the exception of E10.5 whole genome bisulphite sequencing analysis, for which n=39 embryos from n=4 litters were pooled prior to DNA extraction and library preparation.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
No randomisation was carried out as animals/cell lines were assigned to groups based on their genetics. Randomisation was not an applicable part of the study design. However, for embryo comparisons, test (i.e. gene knockout) and control (i.e. wild type) samples were isolated from littermates to carefully control for differences in genetic background and developmental timing. This is discussed in the Methods.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
For LC/MS experiments, test (i.e. gene knockout) and control (i.e. wild type) samples were isolated from littermates to carefully control for differences in genetic background and developmental timing. LC/MS data was gathered prior to availability of the genotyping results. Blinding was not carried out for other experiments as the experimental set-up excluded this possibility. Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed). n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons Test values indicating whether an effect is present Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
The following publicly available softwares were used: QUMA, Trim Galore, Bismark, Methpipe, Bedtools, Tophat, Bowtie, Bowtie, HTSeq, RnBeads, DESeq2, and ChromHMM, GSEA and R. All versions and options used are detailed in the Methods section.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a third party.
All non-commercially available materials are readily available for distribution from the authors.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
